Inhibitors of β-Amyloid Formation Based on the β-Secretase Cleavage Site
- 5 February 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 268 (1) , 133-135
- https://doi.org/10.1006/bbrc.2000.2098
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- Purification and cloning of amyloid precursor protein β-secretase from human brainNature, 1999
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- The Alzheimer family of diseases: Many etiologies, one pathogenesis?Proceedings of the National Academy of Sciences, 1997
- Amyloid precursor protein truncated at any of the ?-secretase sites is not cleaved to ?-amyloidJournal of Neuroscience Research, 1996
- Therapeutic Approaches Related to Amyloid-.beta. Peptide and Alzheimer's DiseaseJournal of Medicinal Chemistry, 1995
- Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolismNeuron, 1995
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984